Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY27.02 CNY
Change Today -0.66 / -2.38%
Volume 5.1M
600613 On Other Exchanges
Symbol
Exchange
Shanghai
Shanghai
As of 3:05 AM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

shanghai shenqi pharmaceut-a (600613) Snapshot

Open
CNY27.45
Previous Close
CNY27.68
Day High
CNY28.11
Day Low
CNY26.98
52 Week High
04/24/15 - CNY29.82
52 Week Low
07/24/14 - CNY14.60
Market Cap
11.5B
Average Volume 10 Days
6.8M
EPS TTM
CNY0.46
Shares Outstanding
399.4M
EX-Date
--
P/E TM
59.3x
Dividend
CNY0.07
Dividend Yield
--
Current Stock Chart for SHANGHAI SHENQI PHARMACEUT-A (600613)

Related News

No related news articles were found.

shanghai shenqi pharmaceut-a (600613) Related Businessweek News

No Related Businessweek News Found

shanghai shenqi pharmaceut-a (600613) Details

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. produces and distributes pharmaceutical products primarily in China. The company offers bacitracin ointment, glucose injections, cantharidate injections, and other products. Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. is based in Shanghai, China.

shanghai shenqi pharmaceut-a (600613) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shanghai shenqi pharmaceut-a (600613) Key Developments

Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. Proposes Cash Dividend for 2014

Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. announced that at the AGM to be held on May 26, 2015, the shareholders will consider cash dividend of CNY 0.6500 (tax included) per 10 shares for 2014.

Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. to Report Fiscal Year 2014 Results on Apr 30, 2015

Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. announced that they will report fiscal year 2014 results on Apr 30, 2015

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Announces Earnings Results for the First Nine Months of 2014

Shanghai Shenqi Pharmaceutical Investment Management Co. Ltd. announced earnings results for the first nine months of 2014. For the period, the company reported basic earnings per share were CNY 0.30 and weighted average return on net assets was 7.28%. Net profit was CNY 135 million, jumping 131% from a year earlier. Operating revenue reached CNY 879 million, hiking 68.35%, due to increasing operating revenue from affiliated companies.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600613:CH CNY27.02 CNY -0.66

600613 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600613.
View Industry Companies
 

Industry Analysis

600613

Industry Average

Valuation 600613 Industry Range
Price/Earnings 74.4x
Price/Sales 8.9x
Price/Book 6.0x
Price/Cash Flow 56.8x
TEV/Sales 8.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI SHENQI PHARMACEUT-A, please visit www.613904.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.